FI862314A0 - Pyridin-derivat, deras framstaellning och anvaendning. - Google Patents

Pyridin-derivat, deras framstaellning och anvaendning.

Info

Publication number
FI862314A0
FI862314A0 FI862314A FI862314A FI862314A0 FI 862314 A0 FI862314 A0 FI 862314A0 FI 862314 A FI862314 A FI 862314A FI 862314 A FI862314 A FI 862314A FI 862314 A0 FI862314 A0 FI 862314A0
Authority
FI
Finland
Prior art keywords
pyridine derivatives
deras framstaellning
framstaellning och
och anvaendning
anvaendning
Prior art date
Application number
FI862314A
Other languages
English (en)
Other versions
FI84827B (fi
FI84827C (fi
FI862314A (fi
Inventor
Hans-Guenther Hege
Gerhard Eisen
Horst Koenig
Philipsborn Gerda Von
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI862314A0 publication Critical patent/FI862314A0/fi
Publication of FI862314A publication Critical patent/FI862314A/fi
Publication of FI84827B publication Critical patent/FI84827B/fi
Application granted granted Critical
Publication of FI84827C publication Critical patent/FI84827C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI862314A 1985-06-01 1986-05-30 Foerfarande foer framstaellning av terapeutiskt anvaendbara pyridinderivat. FI84827C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853519693 DE3519693A1 (de) 1985-06-01 1985-06-01 Pyridin-derivate, ihre herstellung und verwendung
DE3519693 1985-06-01

Publications (4)

Publication Number Publication Date
FI862314A0 true FI862314A0 (fi) 1986-05-30
FI862314A FI862314A (fi) 1986-12-02
FI84827B FI84827B (fi) 1991-10-15
FI84827C FI84827C (fi) 1992-01-27

Family

ID=6272202

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862314A FI84827C (fi) 1985-06-01 1986-05-30 Foerfarande foer framstaellning av terapeutiskt anvaendbara pyridinderivat.

Country Status (13)

Country Link
US (1) US4730042A (fi)
EP (1) EP0204269B1 (fi)
JP (1) JPS61282360A (fi)
AT (1) ATE53837T1 (fi)
AU (1) AU587034B2 (fi)
CA (1) CA1288102C (fi)
DE (2) DE3519693A1 (fi)
DK (1) DK159114C (fi)
ES (1) ES8705448A1 (fi)
FI (1) FI84827C (fi)
HU (1) HU196199B (fi)
IL (1) IL78666A (fi)
ZA (1) ZA864041B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
EP1169322B8 (en) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
WO2001003682A2 (en) * 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
CA2383252A1 (en) * 1999-08-24 2001-03-01 Medicure International Inc. Treatment of cardiovascular related pathologies
PT1268498E (pt) 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
WO2001072309A2 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
WO2002004421A2 (en) 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
WO2006002549A1 (en) * 2004-07-07 2006-01-12 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
JP2008517956A (ja) * 2004-10-28 2008-05-29 メディキュア・インターナショナル・インコーポレーテッド 二重の抗血小板性/抗凝固性ピリドキシン類似体
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
WO2007059631A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies
KR102240821B1 (ko) * 2017-03-13 2021-04-15 광주과학기술원 P2x1 및 p2x3 수용체 길항제로 사용되는 신규한 5-히드록시 피리딘계 화합물 및 이를 포함하는 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
IL62602A (en) * 1980-05-19 1984-06-29 Labaz Sanofi Nv Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them
IN156817B (fi) * 1981-02-10 1985-11-09 Scras

Also Published As

Publication number Publication date
HUT41795A (en) 1987-05-28
FI84827B (fi) 1991-10-15
ATE53837T1 (de) 1990-06-15
JPS61282360A (ja) 1986-12-12
CA1288102C (en) 1991-08-27
HU196199B (en) 1988-10-28
FI84827C (fi) 1992-01-27
EP0204269B1 (de) 1990-05-02
DK159114C (da) 1991-02-11
EP0204269A1 (de) 1986-12-10
ES8705448A1 (es) 1987-05-01
DE3670841D1 (de) 1990-06-07
AU587034B2 (en) 1989-08-03
IL78666A (en) 1989-09-28
DK254386D0 (da) 1986-05-30
ES555545A0 (es) 1987-05-01
DE3519693A1 (de) 1987-01-02
AU5809586A (en) 1986-12-04
FI862314A (fi) 1986-12-02
ZA864041B (en) 1987-01-28
IL78666A0 (en) 1986-08-31
US4730042A (en) 1988-03-08
DK254386A (da) 1986-12-02
DK159114B (da) 1990-09-03

Similar Documents

Publication Publication Date Title
FI853625L (fi) Tetralinderivat, deras framstaellning och anvaendning.
FI862314A (fi) Pyridin-derivat, deras framstaellning och anvaendning.
FI853622A0 (fi) Diarylacetylener, deras framstaellning och anvaendning.
ES525122A0 (es) Procedimiento para preparar derivados de piridina
FI833918A (fi) -karboliner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat
FI853624L (fi) 1-substituerade tetralinderivat, deras framstaellning och anvaendning.
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
FI884524A0 (fi) Biskarbamatbaserade herbicidkompositioner och foerfarande foer bekaempning av ograes med dessa.
FI900646A0 (fi) Foerfarande foer framstaellning av fenylhydrazoner och ur dessa erhaollna laekemedel och kosmetiska aemnen.
DK313587A (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
ATE46687T1 (de) Basisch substituierte phenylacetaldehyde, ihre herstellung und diese enthaltende arzneimittel.
SE8400118L (sv) Substituerade karboxi-tiazolo/3,2-a/pyrimidinderivat och forfarande for deras framstellning
ATE47392T1 (de) 4-substituierte 10-cyanmethylen-thieno(4,3-e>benzo-azepine.
FI821141L (fi) 5,6-dihydro-11-alkylen-morfantridin-6-one, deras framstaellning och dessa innehaollande laekemedel
DE3879709D1 (de) Platin-arzneimittel.
ATE78466T1 (de) 3-phenyl-2-styryl-pyrrolidine, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BASF AKTIENGESELLSCHAFT